SECURITIES AND EXCHANGE COMMISSION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; PROPOSED COLLECTION; COMMENT REQUEST; EXTENSION: RULE 15C3-1

WASHINGTON, April 1 -- Securities And Exchange Commission has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Extension: Rule 15c3-1. The notic... Read More

SECURITIES AND EXCHANGE COMMISSION ISSUES NOTICE: SELF-REGULATORY ORGANIZATIONS; NASDAQ GEMX, LLC; NOTICE OF FILING AND IMMEDIATE EFFECTIVENESS OF PROPOSED RULE CHANGE TO EXTEND THE DESIGNATED DATE FOR REMOVAL OF THE EXCHANGE'S DEDICATED GPS ANTENNA SERVICE UNDER RULE GENERAL 8, SECTION 1(D)

WASHINGTON, April 1 -- Securities And Exchange Commission has issued a notice called: Self-Regulatory Organizations; Nasdaq GEMX, LLC; Notice of Filing and Immediate Effectiveness of Proposed Rule Cha... Read More

SECURITIES AND EXCHANGE COMMISSION ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES; PROPOSED COLLECTION; COMMENT REQUEST; EXTENSION: RULE 8C-1

WASHINGTON, April 1 -- Securities And Exchange Commission has issued a notice called: Agency Information Collection Activities; Proposed Collection; Comment Request; Extension: Rule 8c-1. The notice ... Read More

POSTAL SERVICE ISSUES NOTICE: PRODUCT CHANGE-PRIORITY MAIL EXPRESS, PRIORITY MAIL, AND USPS GROUND ADVANTAGE NEGOTIATED SERVICE AGREEMENTS, PRIORITY MAIL, AND USPS GROUND ADVANTAGE NEGOTIATED SERVICE AGREEMENTS

WASHINGTON, April 1 -- Postal Service has issued a notice called: Product Change-Priority Mail Express, Priority Mail, and USPS Ground Advantage Negotiated Service Agreements, Priority Mail, and USPS ... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

Singapore Clinical Trial: An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of BAY 3771249 as monotherapy or combination with other cancer treatments in participants with solid tumors harboring a KRAS G12D mutation

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'An open-label study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and ... Read More

Singapore Clinical Trial: A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of asciminib in pediatric participants newly diagnosed or previously treated with Philadelphia positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) with or without known T315I mutation.

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A phase II, multicenter, open-label, single arm study to evaluate the safety and efficacy of ascim... Read More

• ««
• «
• 45882
• 45883
• 45884
• 45885
• 45886
• 45887
• 45888
• 45889
• 45890
• 45891
• »
• »»